G. Hong et al. / Tetrahedron xxx (2015) 1e6
5
(m, 2H), 7.05 (d, J¼7.6 Hz, 2H), 2.32 (s, 3H), 2.29 (s, 3H). 13C NMR
7.31 (t, J¼7.6 Hz, 2H), 7.09 (t, J¼7.6 Hz, 1H), 2.27e2.19 (m, 1H),
1.97e1.81 (m, 4H), 1.73e1.52 (m, 4H), 1.32e1.25 (m, 2H). 13C NMR
(100 MHz, CDCl3):
d 165.7, 135.2, 135.1, 133.1, 131.8, 131.3, 129.7,
128.8, 127.4, 127.1, 123.5, 20.9, 17.8. HRMS (ESI-TOF) m/z: [MþH]þ
(100 MHz, CDCl3): d 174.5, 138.1, 128.9, 124.1, 119.8, 46.6, 29.7, 25.7.
calcd for C15H16NO 226.1232; found 226.1229.
HRMS (ESI-TOF) m/z: [MþH]þ calcd for C13H18NO 204.1388; found
204.1371.
4.2.14. 4-Methyl-N-phenylbenzamide (4n).25 White solid (21 mg,
39%). 1H NMR (400 MHz, CDCl3):
d
7.91 (br s, 1H), 7.76 (d, J¼8.0 Hz,
4.2.23. N-Phenylbutyramide (4w).31 White solid (17 mg, 41%). 1H
2H), 7.63 (d, J¼7.6 Hz, 2H), 7.35 (t, J¼7.6 Hz, 2H), 7.26 (d, J¼8.0 Hz, 2H),
NMR (400 MHz, CDCl3):
d
7.52 (d, J¼7.6 Hz, 2H), 7.42 (br s, 1H), 7.31
7.14 (t, J¼7.6 Hz,1H), 2.41 (s, 3H). 13C NMR (100 MHz, CDCl3):
d
165.8,
(t, J¼7.6 Hz, 2H), 7.09 (t, J¼7.2 Hz, 1H), 2.33 (t, J¼7.6 Hz, 2H),
142.4, 138.1, 132.1, 129.4, 129.1, 127.1, 124.5, 120.2, 21.5. HRMS (ESI-
1.80e1.72 (m, 2H), 0.99 (t, J¼7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3):
TOF) m/z: [MþNa]þ calcd for C14H13NNaO 234.0895; found 234.0891.
d 171.5, 138.0, 129.0, 124.2, 119.9, 39.7, 19.1, 13.8. HRMS (ESI-TOF) m/
z: [MþH]þ calcd for C10H14NO 164.1075; found 164.1063.
4.2.15. 2-Methyl-N-phenylbenzamide (4o).25 White solid (23 mg,
44%). 1H NMR (400 MHz, CDCl3):
d
7.61 (d, J¼7.6 Hz, 2H), 7.55 (br s,
4.2.24. N-Phenylpropionamide (4x).31 White solid (15 mg, 39%). 1H
1H), 7.46 (d, J¼7.6 Hz, 1H), 7.38e7.34 (m, 3H), 7.27e7.22 (m, 2H),
NMR (400 MHz, CDCl3):
d
7.52 (d, J¼7.6 Hz, 2H), 7.31 (t, J¼7.6 Hz,
7.15 (t, J¼7.2 Hz, 1H), 2.50 (s, 3H). 13C NMR (100 MHz, CDCl3):
2H), 7.09 (t, J¼7.2 Hz, 1H), 2.39 (q, J¼7.6 Hz, 2H), 1.25 (t, J¼7.6 Hz,
d
168.1, 138.0, 136.4, 131.3, 130.3, 129.1, 126.6, 125.9, 124.6, 119.9,
3H). 13C NMR (100 MHz, CDCl3):
d 172.1, 137.9, 128.9, 124.2, 119.8,
19.8. HRMS (ESI-TOF) m/z: [MþH]þ calcd for C14H14NO 212.1075;
30.8, 9.7. HRMS (ESI-TOF) m/z: [MþH]þ calcd for C9H12NO 150.0919;
found 212.1073.
found 150.0917.
4.2.16. 4-Methoxy-N-phenylbenzamide (4p).25 White solid (38 mg,
4.3. Typical procedure for TBPB-mediated reaction of toluene
derivatives with azobenzene
67%). 1H NMR (400 MHz, CDCl3):
d
7.99 (br s, 1H), 7.81 (d, J¼8.8 Hz,
2H), 7.61 (d, J¼7.6 Hz, 2H), 7.34 (t, J¼7.2 Hz, 2H), 7.13 (t, J¼7.6 Hz,1H),
6.93 (d, J¼9.2 Hz, 2H), 3.84 (s, 3H).13C NMR (100 MHz, CDCl3):
d 165.5,
The mixture of azobenzene 1a (0.25 mmol), TBPB (1 mmol) and
toluene derivatives (1 mL) were added into a sealed tube under air.
After being stirred vigorously at 120 ꢀC for 24 h, the mixture was
evaporated under vacuum. The corresponding product was isolated
by silica gel column chromatography with a petroleum ether/ethyl
acetate mixture as eluent.
162.4, 138.1, 129.0, 129.0, 127.1, 124.4, 120.3, 113.9, 55.3. HRMS (ESI-
TOF) m/z: [MþH]þ calcd for C14H14NO2 228.1025; found 228.1028.
4.2.17. 4-Chloro-N-phenylbenzamide (4q).25 White solid (49 mg,
85%). 1H NMR (400 MHz, CDCl3):
d
7.81 (d, J¼8.4 Hz, 2H), 7.62 (d,
J¼7.6 Hz, 2H), 7.47 (d, J¼8.8 Hz, 2H), 7.38 (t, J¼7.6 Hz, 2H), 7.17 (t,
J¼7.6 Hz,1H). 13C NMR (100 MHz, CDCl3):
d 164.7,138.2,137.6, 133.3,
4.3.1. 3-Methyl-N-phenylbenzamide (4y).25 Pale yellow solid
129.2, 129.1, 128.7, 124.8, 120.3. HRMS (ESI-TOF) m/z: [MþH]þ calcd
(41 mg, 77%). 1H NMR (400 MHz, CDCl3):
d 7.97 (br s, 1H), 7.67e7.61
for C13H11ClNO 232.0529; found 232.0534.
(m, 4H), 7.37e7.32 (m, 4H), 7.13 (t, J¼7.6 Hz, 1H), 2.40 (s, 3H). 13
C
NMR (100 MHz, CDCl3):
d 166.1, 138.7, 138.0, 135.0, 132.6, 129.1,
4.2.18. 4-Bromo-N-phenylbenzamide (4r).25 White solid (62 mg,
128.7, 127.8, 124.5, 123.9, 120.3, 21.4. HRMS (ESI-TOF) m/z: [MþH]þ
91%). 1H NMR (400 MHz, CDCl3):
d
7.84 (s, 1H), 7.75e7.61 (m, 3H),
calcd for C14H14NO 212.1075; found 212.1068.
7.49e7.35 (m, 3H), 7.26e7.23 (m, 3H). 13C NMR (100 MHz, CDCl3):
d
163.5, 137.6, 132.0, 131.6, 129.2, 128.7, 128.6, 124.8, 120.3. HRMS
4.3.2. 4-Fluoro-N-phenylbenzamide (4z).26 Pale yellow solid
(ESI-TOF) m/z: [MþNa]þ calcd for C13H10BrNNaO 297.9843; found
(44 mg, 81%). 1H NMR (400 MHz, CDCl3):
d
7.91e7.85 (m, 2H), 7.82
(br s, 1H), 7.62 (d, J¼7.6 Hz, 2H), 7.38 (t, J¼7.6 Hz, 2H), 7.19e7.13 (m,
3H). 13C NMR (100 MHz, CDCl3):
166.2, 164.7, 163.7, 137.8, 131.2,
297.9837.
d
4.2.19. 3-Fluoro-N-phenylbenzamide (4s).25 White solid (43 mg,
129.5, 129.1, 124.7, 120.3, 115.9 (J¼21.9 Hz). HRMS (ESI-TOF) m/z:
81%). 1H NMR (400 MHz, CDCl3):
d
7.93 (br s, 1H),7.62 (d, J¼8.0 Hz,
[MþH]þ calcd for C13H11FNO 216.0825; found 216.0821.
3H), 7.59e7.55 (m, 1H), 7.47e7.41 (m, 1H), 7.37 (t, J¼7.6 Hz, 2H),
7.26e7.23 (m, 1H), 7.19e7.14 (m, 1H). 13C NMR (100 MHz, CDCl3):
4.3.3. 4-Cyano-N-phenylbenzamide (4aa).32 White solid (12 mg,
d
164.5, 164.1, 161.6, 137.6, 137.2, 130.5, 129.2, 124.9, 122.5, 120.4,
20%). 1H NMR (400 MHz, CDCl3):
d
7.97 (d, J¼8.4 Hz, 2H), 7.94 (br s,
119.0 (J¼21.1 Hz), 114.6 (J¼22.8 Hz). HRMS (ESI-TOF) m/z: [MþNa]þ
1H), 7.77 (d, J¼8.4 Hz, 2H), 7.63 (d, J¼8.0 Hz, 2H), 7.39 (t, J¼7.6 Hz,
calcd for C13H10FNNaO 238.0644; found 238.0642.
2H), 7.20 (t, J¼7.6 Hz,1H). 13C NMR (100 MHz, CDCl3):
d 163.9, 138.9,
137.3, 132.6, 129.2, 127.8, 125.3, 120.4, 117.9, 115.4. HRMS (ESI-TOF)
4.2.20. Methyl 4-(phenylcarbamoyl)benzoate (4t).28 White solid
m/z: [MþH]þ calcd for C14H11N2O 223.0871; found 223.0878.
(24 mg, 38%). 1H NMR (400 MHz, CDCl3):
d
8.16 (d, J¼8.4 Hz, 2H), 7.94
(d, J¼8.4 Hz, 2H), 7.85 (s, 1H), 7.65 (d, J¼7.6 Hz, 2H), 7.39 (t, J¼8.0 Hz,
4.3.4. 3,5-Dimethyl-N-phenylbenzamide
(4ab).33 White
7.87 (s, 1H), 7.64 (d,
solid
2H), 7.19 (t, J¼7.6 Hz, 1H), 3.97 (s, 3H). 13C NMR (100 MHz, CDCl3):
(45 mg, 79%). 1H NMR (400 MHz, CDCl3):
d
d
168.1, 166.5, 137.6, 130.1, 129.2, 127.1, 124.9, 120.3, 52.5. HRMS (ESI-
J¼7.6 Hz, 2H), 7.46 (s, 2H), 7.34 (t, J¼7.6 Hz, 2H), 7.17e7.13 (m, 2H),
TOF) m/z: [MþH]þ calcd for C15H14NO3 256.0974; found 256.0982.
2.37 (s, 6H). 13C NMR (100 MHz, CDCl3):
d 166.2, 138.5, 138.1, 135.0,
133.4, 129.1, 124.8, 124.4, 120.2, 21.3. HRMS (ESI-TOF) m/z: [MþH]þ
4.2.21. N-Phenyl-1-naphthamide (4u).29 White solid (32 mg, 52%).
calcd for C15H16NO 226.1232; found 226.1225.
1H NMR (400 MHz, CDCl3):
d
8.40e8.37 (m, 1H), 7.98 (d, J¼8.4 Hz,
1H), 7.93e7.91 (m, 1H), 7.77e7.69 (m, 4H), 7.62e7.51 (m, 3H), 7.42
(t, J¼8.0 Hz, 2H), 7.19 (t, J¼7.2 Hz, 1H). 13C NMR (100 MHz, CDCl3):
Acknowledgements
d
167.7, 138.0, 133.8, 131.1, 130.9, 129.2, 128.5, 127.4, 126.6, 125.3,
125.1, 124.8, 124.7, 120.0. HRMS (ESI-TOF) m/z: [MþH]þ calcd for
This research was financially supported by the National Natural
Science Foundation of China (21272069, 20672035) and the Fun-
damental Research Funds for the Central Universities and Key
Laboratory of Organofluorine Chemistry, Shanghai Institute of Or-
ganic Chemistry, Chinese Academy of Sciences.
C
17H14NO 248.1075; found 248.1068.
4.2.22. N-Phenylcyclohexanecarboxamide
(4v).30 White
7.52 (d, J¼7.6 Hz, 2H),
solid
(22 mg, 43%). 1H NMR (400 MHz, CDCl3):
d